AmbioPharm

About:

AmbioPharm is a manufacturer of active pharmaceutical ingredients and generic peptides.

Website: http://ambiopharm.com

Top Investors: The Carlyle Group, MVM Life Science Partners

Description:

AmbioPharm is a manufacturing company that manufactures active pharmaceutical ingredients and generic peptides. It undertakes development and production of research-grade complex peptide generic pharmaceuticals and active pharmaceutical ingredients for pre-clinical in-vitro, medicinal, and toxicology programs through its responsive business model and rapid manufacturing processes that enable pharmaceutical and biotech companies to take their peptide projects from preclinical and clinical to commercial quickly at lower costs.

Total Funding Amount:

$24M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

North Augusta, South Carolina, United States

Founded Date:

2005-01-01

Contact Email:

generics(AT)ambiopharm.com

Founders:

Robert Geiger

Number of Employees:

51-100

Last Funding Date:

2018-09-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai